Stock listing

Xetra:NN6 NanoRepro AG Aktie

Home listing (Xetra) of NanoRepro AG

Follow NanoRepro AG into a list and get an email when it puts out news.

Share price · XETR:NN6

€1.41 EUR -0.01 (-1.1%)

Close on Nov 20, 2026

Past year -8.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€1.41 – €1.41 EURNov 20, 2026
Volume
1,722 sharesNov 20, 2026
Market cap
€17.72M EURAt the close on Nov 20, 2026 · price × 12.61M shares outstanding
52-week range
€1.31 – €2.40 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€12,971 EURMedian day 3,936 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
NanoRepro AG logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Xetra:NN6 · Home€1.405 EUR-0.015 (-1.1%)1,722€1.405€1.405€1.405€1.42Close on Nov 20, 2026
Frankfurt:NN6€1.40 EUR+0.065 (+4.9%)—€1.40€1.40€1.40€1.335Close on Nov 20, 2026
Hamburg:NN6€1.40 EUR+0.065 (+4.9%)—€1.40€1.40€1.40€1.335Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · XETR:NN6 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.405-0.015-1.1%€1.405€1.405€1.4051,722
€1.42+0.04+2.9%€1.32€1.44€1.3219,487
€1.38-0.005-0.4%€1.38€1.38€1.3254,789
€1.385-0.015-1.1%€1.44€1.44€1.3256,443
€1.40-0.035-2.4%€1.45€1.45€1.3520,785
€1.435-0.035-2.4%€1.44€1.48€1.4212,818
€1.47-0.07-4.5%€1.56€1.56€1.3839,021
€1.54-0.035-2.2%€1.535€1.55€1.5018,349
€1.575+0.01+0.6%€1.60€1.60€1.535761
€1.565-0.005-0.3%€1.56€1.565€1.53511,111
€1.57-0.005-0.3%€1.585€1.585€1.5353,648
€1.575+0.005+0.3%€1.535€1.58€1.5353,413
€1.570.000.0%€1.54€1.57€1.541,915
€1.57-0.045-2.8%€1.62€1.62€1.542,334
€1.615-0.02-1.2%€1.65€1.65€1.601,002
€1.635+0.06+3.8%€1.575€1.66€1.5728,315
€1.5750.000.0%€1.54€1.60€1.544,224
€1.575+0.01+0.6%€1.58€1.60€1.5452,652
€1.565-0.035-2.2%€1.60€1.60€1.5654,854
€1.60-0.045-2.7%€1.70€1.70€1.5812,600
€1.645-0.065-3.8%€1.72€1.72€1.642,306
€1.71-0.07-3.9%€1.71€1.715€1.641,472
€1.78+0.035+2.0%€1.71€1.78€1.701,853
€1.745+0.02+1.2%€1.71€1.745€1.71150
€1.725-0.005-0.3%€1.72€1.74€1.662,433
€1.73-0.07-3.9%€1.745€1.745€1.6821,642
€1.80+0.04+2.3%€1.76€1.80€1.7151,292
€1.76-0.03-1.7%€1.75€1.78€1.686,463
€1.79+0.06+3.5%€1.72€1.79€1.6952,810
€1.73-0.005-0.3%€1.74€1.80€1.7314,725
€1.735+0.04+2.4%€1.745€1.80€1.73517,247
€1.695+0.045+2.7%€1.75€1.75€1.6419,616
€1.65+0.015+0.9%€1.635€1.695€1.635927
€1.635+0.04+2.5%€1.635€1.695€1.6351
€1.595-0.015-0.9%€1.55€1.70€1.5518,945
€1.61+0.01+0.6%€1.72€1.72€1.571,476
€1.60-0.05-3.0%€1.625€1.65€1.601,093
€1.65-0.03-1.8%€1.69€1.69€1.6415,194
€1.68-0.05-2.9%€1.62€1.68€1.621
€1.73+0.01+0.6%€1.72€1.73€1.6551,622
€1.72+0.085+5.2%€1.655€1.72€1.6551,653
€1.635-0.08-4.7%€1.675€1.715€1.5956,760
€1.715-0.02-1.2%€1.715€1.715€1.6751,885
€1.735+0.02+1.2%€1.74€1.74€1.7352,710
€1.715+0.015+0.9%€1.705€1.73€1.6752,710
€1.70-0.035-2.0%€1.675€1.705€1.6751,195
€1.735+0.04+2.4%€1.74€1.74€1.675552
€1.695-0.02-1.2%€1.74€1.78€1.6753,041
€1.715-0.065-3.7%€1.75€1.75€1.715100
€1.78+0.03+1.7%€1.74€1.78€1.741
€1.75-0.055-3.0%€1.755€1.755€1.7251,275
€1.805+0.14+8.4%€1.68€1.805€1.6812,844
€1.665-0.07-4.0%€1.75€1.75€1.6516,383
€1.735+0.01+0.6%€1.75€1.81€1.6826,210
€1.725+0.035+2.1%€1.77€1.84€1.68521,942
€1.69-0.005-0.3%€1.68€1.735€1.684,836
€1.695-0.045-2.6%€1.74€1.76€1.6420,345
€1.740.000.0%€1.74€1.74€1.74721
€1.74-0.025-1.4%€1.61€1.74€1.6112,421
€1.765-0.095-5.1%€1.86€1.86€1.7510,573
€1.86-0.02-1.1%€1.775€1.86€1.7755,157
€1.88+0.035+1.9%€1.88€1.88€1.805,647
€1.845-0.005-0.3%€1.82€1.87€1.8214,367
€1.85-0.06-3.1%€1.96€1.96€1.826,901
€1.91+0.025+1.3%€1.91€1.91€1.91652
€1.885-0.015-0.8%€1.895€1.90€1.8058,569

Splits

3 splits since 2013 · XETR:NN6 · every price before a split is adjusted for it

DayRatioWhat
52-for-51Split
59-for-57Split
100-for-99Split
Ticker
Xetra:NN6
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Xetra
Currency
EUR

What changed lately

Latest news

NanoRepro AG: Dr. Olaf Stiller, buy

May 29, 2026

Closed €1.83 (+2.8%) on May 29, 2026

All NanoRepro AG news

NanoRepro AG on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
2 in the last 12 months · 2 in all · newest Jun 19, 2026 · oldest 2026
Decks
4 decks · latest Aug 26, 2025

Where NanoRepro AG is listed

ListingExchangeCountryCurrency
Xetra:NN6 · Home listing · This pageXetraGermanyEUR
Tradegate:NN6TradegateGermanyEUR
gettex:NN6gettexGermanyEUR
Frankfurt:NN6FrankfurtGermanyEUR
LS Exchange:657710LS ExchangeGermanyEUR
Stuttgart:NN6StuttgartGermanyEUR
Lang & Schwarz:657710Lang & SchwarzGermanyEUR
Dusseldorf:NN6DusseldorfGermanyEUR
Munich:NN6MunichGermanyEUR
Hamburg:NN6HamburgGermanyEUR

Valuation

Price/book 0.5× against a median of 1.3×: 2nd lowest of 11 Diagnostics & research services companies shown. balance Jun 30, 2025 · price Nov 20, 2026

Enterprise value
€10.43M EUR
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NanoRepro AG · XETR:NN6US$19.45MUS$11.45Mn/an/an/a0.5×n/a0.0×n/a
GeneReach Biotechnology Corp. · TPEX:4171US$21.05MUS$9.04Mn/a1.3×222×1.2×−18.1%0.0×n/a
IVIM Technology, Inc. · KRX:460470US$20.68MUS$10.37Mn/a2.1×n/a1.1×−40.9%0.0×n/a
Q-linea AB · OMXSTO:QLINEAUS$20.66MUS$7.57Mn/a6.9×n/a0.9×n/a0.1×n/a
TFBS Bioscience, Inc. · TPEX:6939US$19.81MUS$7.83Mn/a1.3×n/a0.6×−38.6%0.0×n/a
SANIGEN Co., Ltd. · KRX:188260US$19.66MUS$10.06Mn/a2.2×n/a2.3×−82.6%0.1×n/a
Urteste S.A. · GPW:URTUS$19.24MUS$19.10Mn/a3,525×n/a3.5×n/a0.0×n/a
Genematrix Inc. · KRX:109820US$19.06MUS$6.80Mn/a0.8×31.7×1.4×−1.7%0.0×n/a
Oxford BioDynamics PLC · LSE:OBDUS$18.46MUS$20.77Mn/a14.5×n/a4.3×n/a1.3×n/a
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALBUS$18.41MUS$16.94M1.1×3.6×61.6×0.3×367.8%0.0×n/a
Nexsen Limited · ASX:NXNUS$18.05MUS$15.08Mn/an/an/a4.8×n/a0.0×n/a
Median of the othersUS$19.45MUS$10.22M1.1×2.2×61.6×1.3×−28.3%0.0×

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
4.47 EUR · Analysts' mean
EPS, year to Dec 2026
-0.15 · 2 analysts
Revenue, year to Dec 2026
18.4M · 2 analysts

Decks

DeckKindSlidesDate
Shareholder Meeting (August 2025)Shareholder meeting35 slidesAug 26, 2025
Investor Presentation (May 2016)Investor deck36 slidesMay 12, 2016
Investor Presentation (February 2015)Investor deck20 slidesFebruary 2015
Shareholder Meeting (April 2014)Shareholder meeting22 slidesApr 17, 2014

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue4.65M3.18M38.5M162.7M16.9M1.22M2.75M1.97M1.85M607.7K
Cost of revenue1.70M1.35M28.6M109.0M12.3M949.3K1.14M868.5K1.05M266.8K
Gross profit2.95M1.83M9.90M53.7M4.66M269.0K1.61M1.10M799.0K340.9K
Selling, general and administrative1.90M1.36M1.83M2.82M1.10M748.5K745.6K806.2K657.8K691.9K
Operating income-3.62M-5.34M-4.53M38.8M2.80M-1.18M-323.4K-723.6K-1.10M-1.18M
Depreciation and amortization30.8K21.0K9.20K9.57K1.87M312.2K339.0K193.0K208.8K216.8K
EBITDA-3.59M-5.32M-4.52M38.8M4.67M-869.2K15.6K-530.6K-895.5K-958.7K
Interest expense105.0K105.0K77352.4K18.3K7.48K7.59K10.4K4.91K1.15K
Income before tax-2.74M-4.68M-4.36M38.8M2.78M-1.19M-330.6K-733.9K-1.11M-1.18M
Income tax-692.7K984-640.2K9.03M1.09M119-41.0K190-557.0K-283
Net income-2.05M-4.69M-3.72M29.7M1.69M-1.19M-289.6K-734.1K-551.7K-1.18M
Earnings per share, basic-0.16-0.37-0.292.300.18-0.14-0.03-0.11-0.10-0.27

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents9.10M16.6M31.3M28.0M1.16M737.2K1.77M528.1K530.1K230.5K
Short-term investments4.02M
Receivables545.8K6.25M8.73M32.5M7.32M450.9K603.5K331.6K31.1K35.8K
Inventory901.4K603.9K1.62M17.9M2.57M569.2K677.8K735.1K422.8K403.3K
Current assets15.0M35.3M46.0M79.0M11.1M1.82M3.13M1.66M1.05M794.3K
Property, plant and equipment347.4K503205927503.03K6.39K10.7K13.3K20.5K
Goodwill0
Total assets39.0M41.5M49.5M79.1M11.2M4.80M5.81M4.20M3.51M2.44M
Accounts payable216.1K170.0K371.2K1.99M358.7K116.2K94.9K81.6K167.2K73.6K
Current liabilities299.5K673.4K1.10M11.0M2.20M351.2K120.5K291.1K347.9K92.7K
Long-term debt0150.0K235.97K5.97K13.5K
Total debt150.0K1.35M198.2K238135.9K156.0K13.5K
Total liabilities884.0K1.08M2.04M21.5M3.18M374.2K188.1K373.3K478.8K164.6K
Shareholders' equity38.1M40.4M47.4M57.6M7.99M4.43M5.62M3.82M3.03M2.27M
Shares outstanding12.6M12.7M12.9M12.9M9.33M8.65M8.48M6.84M5.65M4.34M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations9.86M-10.3M13.1M8.16M-1.12M-612.4K-257.6K-1.14M-769.7K-934.6K
Capital spending-402.6K0-3.31M-1.40K-500-618.0K-441.3K-3.80K-800-1.60K
Free cash flow9.46M-10.3M9.84M8.16M-1.12M-612.4K-257.6K-1.15M-770.5K-936.2K
Cash from investing-17.2M-2.03M-3.31M-1.40K-316.8K-618.1K-440.9K-350.1K-380.4K-390.0K
Cash from financing-188.8K-2.37M-6.60M18.7M1.87M198.0K1.94M1.49M1.45M1.44M
Dividends paid-1.93M-6.45M
Share buybacks-188.8K-438.5K01.52M1.31M1.54M
Change in cash-7.50M-14.7M3.24M26.9M426.5K-1.03M1.24M-2.00K299.6K231.5K

Open Financials

Cap table

Built by 6ix from NanoRepro AG’s releases

Common shares
12,613,276
Fully diluted
12,613,276

Fully diluted

LineShares
Common shares12,613,276

Share count over time

CountShares
Nov 22, 202612,613,276

Open Cap table

Log in to ask 6ix AI your own questions about NanoRepro AG.